← Back to Search

Other

Stellate Ganglion Block (SGB) for COVID-19

N/A
Waitlist Available
Led By Ali R Rezai, MD
Research Sponsored by West Virginia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial will test if a nerve block can help people with severe lung injury from COVID-19.

Eligible Conditions
  • COVID-19
  • Acute Respiratory Distress Syndrome
  • Coronavirus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adverse events related to SGB
All Adverse events
Death
Secondary outcome measures
Assessment of respiratory/ pulmonary function
Cardiac function
Radiographic criteria

Side effects data

From 2022 Phase 1 & 2 trial • 20 Patients • NCT05445921
100%
Horner syndrome
45%
Hoarseness
35%
Globus
25%
Brief lightheadedness
20%
Numbness of the face
20%
Mild shortness of breath
15%
Nasal congestion
15%
Pain at the injection site
15%
Fatigue
5%
Cough
5%
Headache
5%
Arm heaviness
5%
Palpitations
5%
Weakness of the neck/back
5%
Bruising of the injection site
5%
Weakness of the arm
5%
Tightness of the back
5%
Chest heaviness
5%
Tightness of the shoulder
100%
80%
60%
40%
20%
0%
Study treatment Arm
Stellate Ganglion Block

Trial Design

1Treatment groups
Experimental Treatment
Group I: Stellate Ganglion Block (SGB)Experimental Treatment1 Intervention
Clinical Stellate ganglion block
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Stellate Ganglion Block
2020
Completed Phase 2
~200

Find a Location

Who is running the clinical trial?

West Virginia UniversityLead Sponsor
178 Previous Clinical Trials
63,029 Total Patients Enrolled
3 Trials studying COVID-19
1,860 Patients Enrolled for COVID-19
Ali R Rezai, MDPrincipal InvestigatorWest Virginia University
1 Previous Clinical Trials
4 Total Patients Enrolled
~1 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top